scispace - formally typeset
M

Meenakshi Balganesh

Researcher at AstraZeneca

Publications -  13
Citations -  583

Meenakshi Balganesh is an academic researcher from AstraZeneca. The author has contributed to research in topics: Efflux & Mycobacterium tuberculosis. The author has an hindex of 9, co-authored 13 publications receiving 535 citations.

Papers
More filters
Journal ArticleDOI

Involvement of efflux pumps in the resistance to peptidoglycan synthesis inhibitors in Mycobacterium tuberculosis.

TL;DR: The study indicates that the efflux pump knockout strains are more susceptible to PSI than the wild type, strongly suggesting an important role for efflux pumps in the intrinsic resistance of M. tuberculosis toPSI.
Journal ArticleDOI

Antituberculosis drugs: reducing efflux=increasing activity.

TL;DR: An experimental approach for studying efflux of compounds selected under the More Medicines for Tuberculosis research project is presented, and a few examples of how, for tuberculosis drug discovery, efflux matters are shown.
Journal ArticleDOI

Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase

TL;DR: This Letter describes the synthesis and SAR studies of this class of molecules by variation of two parts of the molecule, the phenyl and triazolopyrimidine rings, and describes optimisation of enzyme potency, whole cell potency and evidence of mechanism of action.
Journal ArticleDOI

Evaluation of Killing Kinetics of Anti-Tuberculosis Drugs on Mycobacterium tuberculosis Using a Bacteriophage-Based Assay

TL;DR: The concentration- dependent killing of streptomycin, the time-dependent killing of ethambutol and the profiling of an experimental anti-mycobacterial compound are shown for the first time by these 2 methods.